Bilevel noninvasive ventilation provides: 1) IPAP - inspiratory positive airway pressure and 2) EPAP - expiratory PAP at two different levels. This is typically delivered with a tight fitting nasal or face mask which allows for the development of positive airway pressure. The noninvasive therapy should be initiated as early as possible in case of respiratory failure and is best used for short term. "Delta PAP" is the difference between IPAP and EPAP. It directly correlates with the tidal volume delivered. If the "delta PAP" is larger then the tidal volume will be larger and hence it will provide a better alveolar ventilation. INITIAL SETTINGS It is quite safe to start the following initial settings: 1) EPAP 3 to 5 cm H2O (2 - 4 mm Hg) – It can be increased to around 10 cm H2O if ever the oxygenation remains inadequate tidal volume. 2) IPAP 8 to 12 cm H2O (6 - 9 mm Hg) – This can be increased in increments of 2 cm H2O as tolerated by the patient, to a maxim
DEFINITION Emphysematous pyelonephritis is an acute necrotizing infection characterized by gas formation. It is characterized by the presence of gas in and around the kidney. ETIOLOGY E. coli (58%) and K. pneumoniae (21%) are the organisms most commonly isolated. Clostridium and Enterobacter spp may also be responsible, 7% each. RISK FACTORS 1) Diabetes mellitus (70-90%)- usually patients with poor glucose control. High levels of glucose in the urine serve as a substrate for these bacteria and large amounts of gas are generated through natural fermentation 2) Obstruction (25-40%)- it is another common predisposing factor for emphysematous pyelonephritis. For non-diabetics, protein fermentation is a proposed source of gas formation. CLINICAL FEATURES 7% of cases may be asymptomatic. If symptomatic, patients may complain of pneumaturia, irritative lower tract voiding symptoms, flank pain or may present in a severe septic condition with an acute abdomen and hig